Normothermic Machine Perfusion of Donor Livers for Transplantation in the United States

William C. Chapman; Andrew S. Barbas; Anthony M. D’Alessandro; Rodrigo Vianna; Chandrashekhar A. Kubal; Peter L. Abt; Christopher J. Sonnenday; Rolf N. Barth; Josue Alvarez-Casas; Hasan Yersiz; Devin E. Eckhoff; Robert M. Cannon; Yuri Genyk; Linda Sher; Andrew L. Singer; Sandy Feng; Garrett R. Roll; Ari Cohen; Maria B. Majella Doyle; Debra L. Sudan; David Al‐Adra; Adeel Khan; Vijay Subramanian; Nader Abraham; Kim M. Olthoff; Akin Tekin; Lynn Berg; Constantin Coussios; C.G. Morris; Lucy V. Randle; Peter J. Friend; Stuart J. Knechtle

doi:10.1097/sla.0000000000005934

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

NMP did not lower EAD, perhaps related to the inclusion of lower-risk liver donors, as higher-risk donor livers seemed to benefit more. The technology is safe in standard organ recovery and seems to have the greatest benefit for marginal donors.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chapman et al. (2023) studied this question.

synapsesocial.com/papers/69d84222d56ca42147d17dc7 https://doi.org/10.1097/sla.0000000000005934

View at Publisher

Ask AI

Bookmark

Share

Normothermic Machine Perfusion of Donor Livers for Transplantation in the United States

Ask about this paper

Abstract

Discussion

Cite This Study

Normothermic Machine Perfusion of Donor Livers for Transplantation in the United States

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading